VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 124 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,511,885 | -63.3% | 1,011,205 | -43.1% | 0.52% | -57.7% |
| Q2 2023 | $42,260,223 | -4.3% | 1,776,386 | +2.3% | 1.22% | -6.2% |
| Q1 2023 | $44,173,660 | +23.9% | 1,736,386 | +42.3% | 1.30% | +30.3% |
| Q4 2022 | $35,652,996 | +42.4% | 1,220,575 | 0.0% | 1.00% | +37.7% |
| Q3 2022 | $25,034,000 | +122.6% | 1,220,575 | +25.6% | 0.73% | +106.5% |
| Q2 2022 | $11,244,000 | -57.3% | 971,832 | -31.7% | 0.35% | -33.2% |
| Q1 2022 | $26,312,000 | -53.2% | 1,423,053 | -50.0% | 0.53% | +21.4% |
| Q4 2021 | $56,268,000 | +140.4% | 2,846,106 | +100.0% | 0.43% | +27.6% |
| Q3 2021 | $23,408,000 | -19.5% | 1,423,000 | -10.4% | 0.34% | +79.9% |
| Q2 2021 | $29,062,000 | – | 1,589,012 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |